Eleanor Fish: Global outbreaks – Interferons as 1st responders

Overview

Can antivirals that target the host and not the virus improve outcomes for COVID-19 patients? Professor Eleanor Fish from the University of Toronto showed that treatment with interferon-alpha was beneficial in patients with SARS, and now shares early data on COVID-19.

The webinar is moderated by Juan-Carlos Zuniga-Pflücker, the Chair of the Department of Immunology at the University of Toronto.

Speakers

Juan-Carlos Zuniga-Pflücker
Moderator

Juan-Carlos Zuniga-Pflücker is the Chair of the Department of Immunology at the University of Toronto.

Webinar Details

Categories: COVID-19

More Webinars

Anita McElray: Mapping human immune responses to Ebola virus infection provides insight into viral pathogenesis

Fabrizio De Benedetti: Hyperinflammation: hemophagocytic lymphohistiocytosis and macrophage activation syndrome

Claudia Mauri: Regulatory B cells and gut-microbiota: an intricate acting balance in autoimmunity

Qian Zhang: Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Antonio Lanzavecchia: Immunology taught by Plasmodium falciparum

Eric Viver: Harnessing innate immunity in cancer therapy and beyond

Pamela Ohashi: Immunoregulation and the tumor microenvironment

Adrian Hayday: Seeking correlates of protection and correlates of pathology in Covid-19 patients

Michael Reth: Ramos B cell engineering for the evaluation of the humoral anti-SARS-C